Joseph Feingold
About Joseph Feingold
Joseph Feingold Title and Role
Joseph Feingold is currently a Partner, leading the Portfolio, Licensing & Development Practice and serving as the Head of the Advanced Technologies Center of Excellence at Putnam. He has a responsibility for guiding biopharma, diagnostics, and medical device leaders through rigorous analysis and providing critical insights. This role sees him develop comprehensive strategies to aid in business development, clinical development, and commercialization efforts.
Joseph Feingold's Background in Biotechnology
Joseph Feingold began his career as a neuroscientist before transitioning into a role as a biotech strategy expert. Utilizing his combined scientific and entrepreneurial skillsets, he excels in providing high-level strategic advice and insights. His background allows him to adeptly navigate complex challenges in global markets for a diverse range of clients, particularly within the realms of hematology/oncology, neurology, and rare diseases.
Joseph Feingold's Expertise in Advanced Biotechnologies
Joseph Feingold is an authority on novel biotechnologies, which is evidenced by his leadership of Putnam’s Center of Excellence on advanced technologies. His specialization includes cutting-edge sectors such as cell and gene therapies, which often require sophisticated hospital-based administration. Joseph plays a key role in developing new commercialization models for these technologies to ensure they reach the market effectively.
Joseph Feingold's Strategic Development in Biopharmaceuticals
Joseph Feingold supports a wide range of clients across therapeutic areas and modalities by developing strategies for pipeline products and portfolios. His focus on hematology/oncology, neurology, and rare diseases allows for targeted approaches in business development, clinical development, and commercialization. Joseph’s expertise facilitates the seamless integration of scientific advancements into marketable products.